Steve Alas

1.5k total citations
7 papers, 1.3k citations indexed

About

Steve Alas is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Steve Alas has authored 7 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Immunology. Recurrent topics in Steve Alas's work include Monoclonal and Polyclonal Antibodies Research (2 papers), Lymphoma Diagnosis and Treatment (2 papers) and Immune Cell Function and Interaction (2 papers). Steve Alas is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (2 papers), Lymphoma Diagnosis and Treatment (2 papers) and Immune Cell Function and Interaction (2 papers). Steve Alas collaborates with scholars based in United States. Steve Alas's co-authors include Benjamin Bonavida, Christos Emmanouilides, Aïcha Demidem, Nabil Hanna, Kandasamy Hariharan, Purnima Singh, L. David Finger, Junzhuan Qiu, Ren Liu and Li Zheng and has published in prestigious journals such as BioEssays, Cancer Biotherapy and Radiopharmaceuticals and PubMed.

In The Last Decade

Steve Alas

7 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Steve Alas United States	7	657	551	410	405	327	7	1.3k
Gunhild Trøen Norway	21	329 0.5×	271 0.5×	439 1.1×	226 0.6×	199 0.6×	46	1.1k
Federica Frezzato Italy	23	307 0.5×	191 0.3×	546 1.3×	553 1.4×	439 1.3×	61	1.2k
Michael Grau Germany	17	394 0.6×	417 0.8×	597 1.5×	274 0.7×	496 1.5×	30	1.3k
Carmela Gurrieri Italy	18	196 0.3×	393 0.7×	915 2.2×	304 0.8×	353 1.1×	46	1.5k
Franz Kohlhuber Germany	15	161 0.2×	825 1.5×	1.1k 2.8×	164 0.4×	357 1.1×	17	1.8k
Christian R. Geest Netherlands	10	300 0.5×	162 0.3×	476 1.2×	454 1.1×	349 1.1×	16	1.1k
Timothy McDonnell United States	12	186 0.3×	406 0.7×	343 0.8×	120 0.3×	82 0.3×	19	866
Theresa A. Mays United States	10	152 0.2×	477 0.9×	773 1.9×	69 0.2×	126 0.4×	15	1.2k
A. W. Tolcher United States	19	148 0.2×	583 1.1×	821 2.0×	72 0.2×	168 0.5×	107	1.3k
Kilannin Krysiak United States	13	228 0.3×	240 0.4×	371 0.9×	126 0.3×	105 0.3×	26	794

Countries citing papers authored by Steve Alas

Since Specialization

Citations

This map shows the geographic impact of Steve Alas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steve Alas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steve Alas more than expected).

Fields of papers citing papers by Steve Alas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steve Alas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steve Alas. The network helps show where Steve Alas may publish in the future.

Co-authorship network of co-authors of Steve Alas

This figure shows the co-authorship network connecting the top 25 collaborators of Steve Alas. A scholar is included among the top collaborators of Steve Alas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steve Alas. Steve Alas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Shen, Binghui, Purnima Singh, Ren Liu, et al.. (2005). Multiple but dissectible functions of FEN‐1 nucleases in nucleic acid processing, genome stability and diseases. BioEssays. 27(7). 717–729. 123 indexed citations

2.

Alas, Steve & Benjamin Bonavida. (2003). Inhibition of constitutive STAT3 activity sensitizes resistant non-Hodgkin's lymphoma and multiple myeloma to chemotherapeutic drug-mediated apoptosis.. PubMed. 9(1). 316–26. 198 indexed citations

3.

Alas, Steve, et al.. (2002). Rituximab modifies the cisplatin-mitochondrial signaling pathway, resulting in apoptosis in cisplatin-resistant non-Hodgkin's lymphoma.. PubMed. 8(3). 836–45. 75 indexed citations

4.

Alas, Steve, Christos Emmanouilides, & Benjamin Bonavida. (2001). Inhibition of interleukin 10 by rituximab results in down-regulation of bcl-2 and sensitization of B-cell non-Hodgkin's lymphoma to apoptosis.. PubMed. 7(3). 709–23. 230 indexed citations

5.

Alas, Steve & Benjamin Bonavida. (2001). Rituximab inactivates signal transducer and activation of transcription 3 (STAT3) activity in B-non-Hodgkin's lymphoma through inhibition of the interleukin 10 autocrine/paracrine loop and results in down-regulation of Bcl-2 and sensitization to cytotoxic drugs.. PubMed. 61(13). 5137–44. 244 indexed citations

6.

Alas, Steve, Benjamin Bonavida, & Christos Emmanouilides. (2000). Potentiation of fludarabine cytotoxicity on non-Hodgkin's lymphoma by pentoxifylline and rituximab.. PubMed. 20(5A). 2961–6. 58 indexed citations

7.

Demidem, Aïcha, et al.. (1997). Chimeric Anti-CD20 (IDEC-C2B8) Monoclonal Antibody Sensitizes a B Cell Lymphoma Cell Line to Cell Killing by Cytotoxic Drugs. Cancer Biotherapy and Radiopharmaceuticals. 12(3). 177–186. 328 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact